Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 540679 | NSE Symbol : SMSLIFE | ISIN : INE320X01016 | Industry : Pharmaceuticals |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
08-Nov-2024	13-Nov-2024	Quarterly Results	SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve Unaudited financial results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30. 2024 and any other item as may be decided by the Board of Directors. Outcome of Board meeting (As Per BSE Announcement Dated on: 13/11/2024)
06-Aug-2024	09-Aug-2024	Quarterly Results	SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2024 inter alia to consider and approve 1. Unaudited financial results (Standalone and Consolidated) of the Company for the quarter ended June 30 2024 2. Board report for the year 2023-24 and fixing the date of 18th Annual General Meeting 3. any other item as may be decided by the Board of Directors. Outcome of Board meeting (As Per BSE Announcement Dated on 09.08.2024)
21-May-2024	27-May-2024	Dividend	SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2024 inter alia to consider and approve 1. Audited financial results (Standalone and Consolidated) of the Company for the fourth quarter and year ended March 31 2024. 2. Discuss to recommend dividend for the financial year 2023-24 if any. 3. any other item as may be decided by the Board of Directors. Financial results (Q4/F24) Mr. Mukesh P. Shewalkar is appointed as Senior Management Personnel of the Company, designated as General Manager (R&D head) . Appointment of Cost Auditors & Reappointment of Secretarial Auditor for the year 2024-25. (As Per BSE Announcement Dated on 27/05/2024)
03-Feb-2024	10-Feb-2024	Quarterly Results	SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 inter alia to consider and approve 1. Unaudited financial results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31 2023. 2. Request of reclassification received from Mr. Ramesh Babu promoter of the Company. 3. Any other item as may be decided by the Board of Directors. Outcome of Board Meeting. (As Per BSE Announcement Dated on 10.02.2024)
04-Nov-2023	11-Nov-2023	Quarterly Results	SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2023 inter alia to consider and approve the unaudited financial results (Standalone and Consolidated) for the quarter and half year ended Sept 30 2023 along with any other items as may be decided by the Board of Directors. Enclosed is the Outcome of the Board Meeting. (As Per BSE Announcement dated on 11.11.2023)
02-Aug-2023	08-Aug-2023	Quarterly Results	SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2023 inter alia to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2023 Board Report for the year 2022-23 and fixing the date for 17th Annual General Meeting along with any other items as may be decided by the Board of Directors. Enclosed is the Outcome of the Board Meeting (Q1F24 Results / AGM date / Board Report approval). (As Per BSE Announcement Dated on 08.08.2023)
22-May-2023	29-May-2023	Accounts	SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31 2023 and recommend dividend if any for the year ended March 31 2023. Board Meeting Outcome for Outcome Of 85Th Board Meeting (29.05.2023) 1. Board of Directors has approved the Audited [Standalone & Consolidated] Financial results for the quarter and year ended 31st March, 2023. 2. Board of Directors has recommended a dividend of ?1.50/- (15%) per equity share of ?10/- face value, for the year 2022-23, subject to the approval of the Shareholders. (As Per BSE Announcement Dated on 29.05.2023) Secretarial Auditor and Cost Auditor are reappointed for the year 2023-24. Board of Directors of M/s Mahi Drugs Private Limited (subsidiary Company/ Mahi Drugs) at its Meeting held on May 29, 2023, has approved the reappointment of M/s. Rambabu & Co, Chartered Accountants, Hyderabad as the Statutory Auditors of the subsidiary Company to hold office for a further period of 5 (five) years till the conclusion of the Annual General Meeting (AGM) to be held in the year 2028, subject to the approval of Shareholders of Mahi Drugs in the ensuing general meeting. (As Per BSE Announcement Dated on 30.05.2023)
03-Feb-2023	10-Feb-2023	Quarterly Results	SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2023 inter alia to consider and approve the unaudited financial results (Standalone and Consolidated) of the Company for the quarter ended December 31 2022 and any other item as may be decided by the Board of Directors. Enclosed is the Outcome of the Board Meeting / Q3 Results. (As per BSE Announcement Dated on 10/02/2023)
07-Nov-2022	14-Nov-2022	Quarterly Results	SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 inter alia to consider and approve i) unaudited financial results (Standalone and Consolidated) of the Company for the quarter and half year ended Sept 30 2022 ii) any other item as may be decided by the Board of Directors. Enclosed is the Outcome of the Board Meeting / Q2 Results. (As Per BSE Announcement Dated on 14.11.2022)
03-Aug-2022	09-Aug-2022	Quarterly Results	SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2022 inter alia to consider and approve i) unaudited financial results (Standalone and Consolidated) of the Company for the quarter ended June 30 2022 ii) any other item as may be decided by the Board of Directors. Enclosed is the Outcome of the Board Meeting. (As Per BSE Announcement Dated on 09.08.2022) Enclosed are copies of the newspaper advertisement. (As Per BSE Announcement Dated 11.08.2022)
21-May-2022	28-May-2022	Accounts	SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2022 inter alia to consider and approve i) audited financial results (Standalone and Consolidated) of the Company for the fourth quarter and year ended March 31 2022 ii) discuss to recommend dividends for the financial year 2021-22 if any iii) any other item as may be decided by the Board of Directors. SMS Lifesciences India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2022, inter alia, has recommended a dividend of Rs. 1.50/- (15%) per equity share Rs. 10/- face value, for the year 2021-22, subject to the approval of the Shareholders at the ensuing 16th Annual General Meeting (AGM) of the Company. Mr. TVVSN Murthy has been reappointed as Managing Director for a further period of 3 (three) years w.e.f. June 1, 2022, subject to the approval of Shareholders. Enclosed is the Outcome of the Board Meeting. (As per BSE Announcement Dated on 28/5/2022) Copy of Audited Results. Secretarial Auditor and Cost Auditor are reappointed for the year 2022-23. Mr. Venkata Praveen Talluri has been appointed as Managing Director and Mr. Madhu Rao Maganty as Nominee Director in Mahi Drugs Private Limited. Enclosed copies of newspaper advertisement. (As Per BSE Announcement Dated on 29.05.2022)
05-Feb-2022	11-Feb-2022	Quarterly Results	SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2022 inter alia to consider and approve Enclosed copy of Board Meeting intimation. Enclosed outcome of Board meeting. (financial results) Re-appolnfmenf of Mr. P Sarafh Kumar [DIN: 01456746] as Independenf Dlrecfor of the Compa ny [whose c urrenl tenure will come to an end on May 24, 2022] for the second tenure of 5 (five) years w.e.1. May 25, 2022. The said appointment shall be subject to the a pproval of the shareholders by way of a Special Resolution in the ensuing General Meeting. (As Per BSE Announcement dated on 11.02.2022) Enclosed copies of newspaper advertisement. (As Per BSE Announcement Dated 14.02.2022)
24-Nov-2021	30-Nov-2021	Subsidiary Company	SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/11/2021 ,inter alia, to consider and approve i) Disinvestment of equity shares of Mahi Drugs Private Limited, a wholly-owned subsidiary of the Company and such other connected matters thereof. ii) Any other items as may be decided by the Board of Directors. Disclosure pursuant to Regulafion 30 of the SEBI (listing Obllgafions and Disclosure Requlremenfs) Regulations, 2015. (As per BSE Announcement Dated on 30/11/2021)
08-Nov-2021	13-Nov-2021	Quarterly Results	Quarterly Results Enclosed copy of Outcome of Board Meeting (As Per BSE Announcement dated on 13.11.2021) Dr. (Mr.) Mannam Malakondaiah [DIN: 01431923] and Dr. (Mr.) Srinivas Samavedam [DIN: 02488555] are appointed as Independent Directors of the Company, with immediate effect, for a term of 5 (five) consecutive years, subject to the approval of Shareholders. (As Per BSE Announcement Dated on 14.11.2021)
27-Aug-2021	02-Sep-2021	AGM	Inter alia, to consider the following: i) approval of the Board Report for the year 2020-21, ii) fixing the date of 15th Annual General Meeting, iii) appointment of Director, iv) any other items as may be decided by the Board of Directors. Otcome of Board meeting held on September 2, 2021. (As per BSE Announcement Dated on 2/9/2021)

1 2

LOGIN HERE

SMS Lifesciences India Ltd

Board Meeting